611 related articles for article (PubMed ID: 21555710)
1. Duration of treatment with nonsteroidal anti-inflammatory drugs and impact on risk of death and recurrent myocardial infarction in patients with prior myocardial infarction: a nationwide cohort study.
Schjerning Olsen AM; Fosbøl EL; Lindhardsen J; Folke F; Charlot M; Selmer C; Lamberts M; Bjerring Olesen J; Køber L; Hansen PR; Torp-Pedersen C; Gislason GH
Circulation; 2011 May; 123(20):2226-35. PubMed ID: 21555710
[TBL] [Abstract][Full Text] [Related]
2. [Comment on "Duration of treatment with nonsteroidal anti-inflammatory drugs and impact on risk of death and recurrent myocardial infarction in patients with prior myocardial infarction. A Nationwide Cohort Study].
Mimoso J
Rev Port Cardiol; 2011 Jul; 30(7-8):689-90. PubMed ID: 22005315
[TBL] [Abstract][Full Text] [Related]
3. Long-term cardiovascular risk of nonsteroidal anti-inflammatory drug use according to time passed after first-time myocardial infarction: a nationwide cohort study.
Olsen AM; Fosbøl EL; Lindhardsen J; Folke F; Charlot M; Selmer C; Bjerring Olesen J; Lamberts M; Ruwald MH; Køber L; Hansen PR; Torp-Pedersen C; Gislason GH
Circulation; 2012 Oct; 126(16):1955-63. PubMed ID: 22965337
[TBL] [Abstract][Full Text] [Related]
4. Risk of death or reinfarction associated with the use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs after acute myocardial infarction.
Gislason GH; Jacobsen S; Rasmussen JN; Rasmussen S; Buch P; Friberg J; Schramm TK; Abildstrom SZ; Køber L; Madsen M; Torp-Pedersen C
Circulation; 2006 Jun; 113(25):2906-13. PubMed ID: 16785336
[TBL] [Abstract][Full Text] [Related]
5. Increased mortality and cardiovascular morbidity associated with use of nonsteroidal anti-inflammatory drugs in chronic heart failure.
Gislason GH; Rasmussen JN; Abildstrom SZ; Schramm TK; Hansen ML; Fosbøl EL; Sørensen R; Folke F; Buch P; Gadsbøll N; Rasmussen S; Poulsen HE; Køber L; Madsen M; Torp-Pedersen C
Arch Intern Med; 2009 Jan; 169(2):141-9. PubMed ID: 19171810
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular risks of nonsteroidal antiinflammatory drugs in patients after hospitalization for serious coronary heart disease.
Ray WA; Varas-Lorenzo C; Chung CP; Castellsague J; Murray KT; Stein CM; Daugherty JR; Arbogast PG; García-Rodríguez LA
Circ Cardiovasc Qual Outcomes; 2009 May; 2(3):155-63. PubMed ID: 20031832
[TBL] [Abstract][Full Text] [Related]
7. Ongoing treatment with non-steroidal anti-inflammatory drugs at time of admission is associated with poorer prognosis in patients with first-time acute myocardial infarction.
Lamberts M; Fosbøl EL; Olsen AM; Hansen ML; Folke F; Kristensen SL; Olesen JB; Hansen PR; Køber L; Torp-Pedersen C; Gislason GH
Int J Cardiol; 2013 Sep; 168(2):832-7. PubMed ID: 23117013
[TBL] [Abstract][Full Text] [Related]
8. Does the varied use of NSAIDs explain the differences in the risk of myocardial infarction?
van Staa TP; Rietbrock S; Setakis E; Leufkens HG
J Intern Med; 2008 Nov; 264(5):481-92. PubMed ID: 18624902
[TBL] [Abstract][Full Text] [Related]
9. Use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs in high doses increases mortality and risk of reinfarction in patients with prior myocardial infarction.
Sørensen R; Abildstrom SZ; Torp-Pedersen C; Gislason GH
J Cardiovasc Nurs; 2008; 23(1):14-9. PubMed ID: 18158501
[TBL] [Abstract][Full Text] [Related]
10. Association of NSAID use with risk of bleeding and cardiovascular events in patients receiving antithrombotic therapy after myocardial infarction.
Schjerning Olsen AM; Gislason GH; McGettigan P; Fosbøl E; Sørensen R; Hansen ML; Køber L; Torp-Pedersen C; Lamberts M
JAMA; 2015 Feb; 313(8):805-14. PubMed ID: 25710657
[TBL] [Abstract][Full Text] [Related]
11. Association between nonnaproxen NSAIDs, COX-2 inhibitors and hospitalization for acute myocardial infarction among the elderly: a retrospective cohort study.
Rahme E; Watson DJ; Kong SX; Toubouti Y; LeLorier J
Pharmacoepidemiol Drug Saf; 2007 May; 16(5):493-503. PubMed ID: 17086567
[TBL] [Abstract][Full Text] [Related]
12. Cause-specific cardiovascular risk associated with nonsteroidal anti-inflammatory drugs among myocardial infarction patients--a nationwide study.
Olsen AM; Fosbøl EL; Lindhardsen J; Andersson C; Folke F; Nielsen MB; Køber L; Hansen PR; Torp-Pedersen C; Gislason GH
PLoS One; 2013; 8(1):e54309. PubMed ID: 23382889
[TBL] [Abstract][Full Text] [Related]
13. Risk of myocardial infarction and death associated with the use of nonsteroidal anti-inflammatory drugs (NSAIDs) among healthy individuals: a nationwide cohort study.
Fosbøl EL; Gislason GH; Jacobsen S; Folke F; Hansen ML; Schramm TK; Sørensen R; Rasmussen JN; Andersen SS; Abildstrom SZ; Traerup J; Poulsen HE; Rasmussen S; Køber L; Torp-Pedersen C
Clin Pharmacol Ther; 2009 Feb; 85(2):190-7. PubMed ID: 18987620
[TBL] [Abstract][Full Text] [Related]
14. Nonsteroidal antiinflammatory drug use and cardiovascular risks after coronary stent implantation.
Schmidt M; Pedersen L; Maeng M; Lassen JF; Lash TL; Nielsen TT; Sørensen HT
Pharmacotherapy; 2011 May; 31(5):458-68. PubMed ID: 21923427
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous assessment of short-term gastrointestinal benefits and cardiovascular risks of selective cyclooxygenase 2 inhibitors and nonselective nonsteroidal antiinflammatory drugs: an instrumental variable analysis.
Schneeweiss S; Solomon DH; Wang PS; Rassen J; Brookhart MA
Arthritis Rheum; 2006 Nov; 54(11):3390-8. PubMed ID: 17075817
[TBL] [Abstract][Full Text] [Related]
16. Prognosis following first-time myocardial infarction in patients with psoriasis: a Danish nationwide cohort study.
Ahlehoff O; Gislason GH; Lindhardsen J; Olesen JB; Charlot M; Skov L; Torp-Pedersen C; Hansen PR
J Intern Med; 2011 Sep; 270(3):237-44. PubMed ID: 21362070
[TBL] [Abstract][Full Text] [Related]
17. Nonsteroidal antiinflammatory drugs and the risk of myocardial infarction in the general population.
García Rodríguez LA; Varas-Lorenzo C; Maguire A; González-Pérez A
Circulation; 2004 Jun; 109(24):3000-6. PubMed ID: 15197149
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: high-risk subgroups and time course of risk.
Solomon DH; Avorn J; Stürmer T; Glynn RJ; Mogun H; Schneeweiss S
Arthritis Rheum; 2006 May; 54(5):1378-89. PubMed ID: 16645966
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular events associated with the use of four nonselective NSAIDs (etodolac, nabumetone, ibuprofen, or naproxen) versus a cyclooxygenase-2 inhibitor (celecoxib): a population-based analysis in Taiwanese adults.
Huang WF; Hsiao FY; Wen YW; Tsai YW
Clin Ther; 2006 Nov; 28(11):1827-36. PubMed ID: 17213003
[TBL] [Abstract][Full Text] [Related]
20. Risk of ST versus non-ST elevation myocardial infarction associated with non-steroidal anti-inflammatory drugs.
Grimaldi-Bensouda L; Rossignol M; Danchin N; Steg PG; Bessede G; Ovize M; Cottin Y; Autret-Leca E; Benichou J; Abenhaim L;
Heart; 2011 Nov; 97(22):1834-40. PubMed ID: 21880652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
